PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
Conditions
- Hematologic Malignancies
- Hematopoietic Stem Cell Transplant (HSCT)
Interventions
- DRUG: PUL-042
- DRUG: Placebo
Sponsor
Pulmotect, Inc.
Collaborators